mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.003 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |